mrna-vaccines
(2)
The Virus With a Second Job
Virogin Biotech is trying to turn an old enemy of human cells into a delivery system for cancer treatment. Its first clinical signal is intriguing; the harder test is proving that signal holds up in larger trials.
Marc Montserrat
Marc Montserrat is the Chief Executive Officer of DNA Script, a French-American biotech pioneering enzymatic DNA synthesis - a technology that lets labs print custom DNA on demand, in hours instead of days. A Wharton MBA and industrial engineer by training, Montserrat spent two decades building commercial operations at Ariosa Diagnostics (prenatal testing), Omniome (next-gen sequencing), and Deepcell (AI-powered single-cell analysis) before co-founding Splice Bio and ultimately landing as CEO of DNA Script in October 2024. He was drawn into life sciences after a misdiagnosis scare at 24 that convinced him life was too short to spend on work without meaning.